“`html
Medical Care Technologies Inc. (OTC PINK:MDCE) announced a significant reduction in its share structure as CEO Marshall Perkins voluntarily surrendered 680 million shares of common stock back to the company’s treasury. The company’s authorized share count remains at approximately 8 billion shares.
MDCE operates in AI healthcare and sports authentication through its subsidiaries Infinite Auctions and Real Game Used. The company is developing a patent-pending AI health diagnostics platform targeting the global healthcare market, which is projected to exceed $1 trillion by 2030.
Positive
CEO surrendered 680 million shares, significantly reducing outstanding share count
Demonstrates management’s commitment to shareholder value
Maintains strong position in AI healthcare and sports authentication markets
Company’s AI health diagnostics platform targets trillion-dollar healthcare market
Negative
Authorized share count remains high at nearly 8 billion shares
09/08/2025 – 09:11 AM
MESA, ARIZONA – Medical Care Technologies Inc. (OTC PINK:MDCE) (“MDCE” or the “Company”) announced today a strategic move aimed at bolstering shareholder value. CEO Marshall Perkins has voluntarily surrendered 680 million shares of the company’s common stock, effectively reducing the outstanding share count by the same amount. This development, considered a material event, will be formally disclosed with OTC Markets within the coming days.
The move signals a commitment to improving MDCE’s capital structure and aligning management’s interests with those of its investors. While this action significantly reduces the outstanding float, the authorized share count remains unchanged at approximately 8 billion shares. Analysts note that this reserve could provide future flexibility for strategic initiatives but also warrants careful management to avoid potential dilution.
“Today’s action demonstrates my unwavering commitment to aligning myself with our shareholders as we continue to scale MDCE’s AI healthcare and sports authentication businesses,” stated CEO Marshall Perkins. “By aggressively reducing the outstanding share count, we are sending a clear signal of confidence in our business model, our subsidiaries, and our path forward.”
Medical Care Technologies Inc. is strategically positioned at the intersection of high-growth sectors, focusing on both AI-powered healthcare solutions and the burgeoning sports memorabilia authentication market through its subsidiaries, Infinite Auctions and Real Game Used. The company’s patent-pending AI health diagnostics platform represents a key growth driver, targeting the global healthcare market, which analysts project to surpass $1 trillion by 2030.
The strategic reduction in outstanding shares is expected to strengthen the Company’s financial foundation, paving the way for continued innovation and enhanced shareholder engagement. This development comes as MDCE intensifies its focus on expanding its portfolio of AI-powered healthcare technologies and supporting the growth of its subsidiaries.
From a technological standpoint, MDCE’s AI health diagnostics platform holds significant potential. Experts believe that AI-driven diagnostics could revolutionize preventative medicine by enabling earlier and more accurate disease detection. However, the company faces competition from established players in the healthcare technology sector and will need to demonstrate strong efficacy and regulatory compliance to achieve widespread adoption.
In the sports authentication arena, the market for authenticated memorabilia is experiencing significant growth, fueled by increasing fan engagement and the rise of online marketplaces. MDCE, through its subsidiaries, is positioning itself to capture a share of this lucrative market by leveraging advanced authentication technologies and establishing partnerships with key industry players.
Medical Care Technologies Inc. (OTC PINK: MDCE) is a forward-looking healthcare and technology company developing a suite of AI-driven diagnostic tools designed to transform preventative medicine, while also operating subsidiaries in the sports memorabilia authentication and auction industries. The Company’s diversified platform targets high-value markets with scalable solutions for patients, providers, collectors, and investors.
This press release may contain forward-looking statements, including but not limited to expectations regarding future business strategy, potential market opportunities, and shareholder value. These statements are based on current beliefs and assumptions of management and are subject to risks and uncertainties that could cause actual results to differ materially. Medical Care Technologies Inc. undertakes no obligation to update any forward-looking statements, except as required by law.
How many shares did MDCE’s CEO surrender to the treasury in September 2025?
MDCE CEO Marshall Perkins voluntarily surrendered 680,000,000 shares of common stock back to the company’s treasury.
What is Medical Care Technologies’ (MDCE) current authorized share count?
MDCE’s authorized share count remains unchanged at 7,979,999,990 shares.
What are Medical Care Technologies’ (MDCE) main business segments?
MDCE operates in AI healthcare technology and sports authentication through its subsidiaries Infinite Auctions and Real Game Used, with a focus on AI health diagnostics.
What is the projected size of the global healthcare market that MDCE is targeting?
MDCE is targeting the global healthcare market that is projected to exceed $1 trillion by 2030.
Who is the current CEO of Medical Care Technologies (MDCE)?
Marshall Perkins is the current CEO of Medical Care Technologies (MDCE).
“`
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/8889.html
